PR-104A
PR-104A is a hypoxia-activated prodrug designed for anticancer research. It is metabolized under low-oxygen conditions to release cytotoxic DNA cross-linking agents, enabling the study of hypoxic tumor targeting in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
680199-06-8
Field of Research
Metabolism Research, Molecular Biology
Smiles
CS (=O) (=O) OCCN (CCBr) c1c (cc (cc1[N+] ([O-]) =O) [N+] ([O-]) =O) C (=O) NCCO
Molecular Formula
C14H19BrN4O9S
Molecular Weight
499.29
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog